Concepedia

Mikko Kuoppamäki

MK

Statistics

Publications

40

Citations

2.3K

H-Index

27

Active since

1992

Affiliations

University of Turku(Current)

Turku University Hospital

Orion Corporation (Finland)

King's College London

Orion Corporation (United Kingdom)

Mikko Kuoppamäki is an author at University of Turku specializing in neuropharmacology, medicine, and pharmacology.

Publications per year

1992–2019

40

Publications

40

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients

Jarmo Hietala, Erkka Syvälahti, Mikko Kuoppamäki et al. · The Lancet · 1995 · 322 citations

Medicine, Neuroscience, Psychiatry +14

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

Jarmo Hietala, Erkka Syvälahti, Harry Vilkman et al. · Schizophrenia Research · 1999 · 244 citations

Medicine, Neuroscience, Psychiatry +16

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor

Esa-Pekka Pälvimäki, Hannu Majasuo, Aki Laakso et al. · Psychopharmacology · 1996 · 200 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists

Mikko Kuoppamäki, Erkka Syvälahti, Jarmo Hietala · European Journal of Pharmacology Molecular Pharmacology · 1993 · 125 citations

Medicine, Pharmacology, Pharmacotherapy +11

Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates

Lance A. Smith, Ghassan Al‐Barghouthy, Sarah Rose et al. · Movement Disorders · 2005 · 112 citations · Full text

Medicine, Neuroscience, Pharmacology +14

1–5 of 40